PYC Therapeutics Ltd banner

PYC Therapeutics Ltd
ASX:PYC

Watchlist Manager
PYC Therapeutics Ltd Logo
PYC Therapeutics Ltd
ASX:PYC
Watchlist
Price: 1.5 AUD 0.33% Market Closed
Market Cap: AU$874.9m

Wall Street
Price Targets

PYC Price Targets Summary
PYC Therapeutics Ltd

Wall Street analysts forecast PYC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PYC is 3.63 AUD with a low forecast of 2.27 AUD and a high forecast of 5.21 AUD.

Lowest
Price Target
2.27 AUD
51% Upside
Average
Price Target
3.63 AUD
142% Upside
Highest
Price Target
5.21 AUD
247% Upside
PYC Therapeutics Ltd Competitors:
Price Targets
TENB
Tenable Holdings Inc
67% Upside
PAYS
Paysign Inc
152% Upside
TCPC
BlackRock TCP Capital Corp
36% Upside
IPAR
Inter Parfums Inc
7% Upside
ESQ
Esquire Financial Holdings Inc
7% Upside
TARA
Protara Therapeutics Inc
286% Upside

Revenue
Forecast

19% / Year
Past Growth
98% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss
19% / Year
Past Growth
98% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss

For the last 14 years the compound annual growth rate for PYC Therapeutics Ltd's revenue is 19%. The projected CAGR for the next 3 years is 98%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PYC's stock price target?
Price Target
3.63 AUD

According to Wall Street analysts, the average 1-year price target for PYC is 3.63 AUD with a low forecast of 2.27 AUD and a high forecast of 5.21 AUD.

What is PYC Therapeutics Ltd's Revenue forecast?
Projected CAGR
98%

For the last 14 years the compound annual growth rate for PYC Therapeutics Ltd's revenue is 19%. The projected CAGR for the next 3 years is 98%.

Back to Top